The Never Ending Struggle Against Development of Drug Resistance

Clin Infect Dis. 2015 Jul 1;61(1):137-8. doi: 10.1093/cid/civ238. Epub 2015 Mar 25.

Authors

Alper Daskapan¹, Ymkje Stienstra², Onno W Akkerman³, Wiel C M de Lange³, Jos G W Kosterink⁴, Tjip S van der Werf², Jan-Willem C Alffenaar¹

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology.
² Department of Internal Medicine-Infectious Diseases.
³ Department of Pulmonary Diseases and Tuberculosis.
⁴ Department of Clinical Pharmacy and Pharmacology Department of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, University of Groningen, University Medical Center Groningen, The Netherlands.

PMID: 25810289
DOI: 10.1093/cid/civ238

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / therapeutic use*
Female
HIV Infections / drug therapy*
Humans
Male
Rifampin / therapeutic use*
Tuberculosis / drug therapy*

Substances

Antitubercular Agents
Rifampin